Skip to Content
Søg Menu

Prophylactic Strategies Improve Tolerability of Sacituzumab Govitecan in HER2-Negative Advanced Breast Cancer

/ Antonio Llombart-Cussac
NBCNBrystcancer Play the Video
Antonio Llombart Cussac

Remarkable Long-term Outcomes for Palbociclib-based Regimens for HR+/HER- Advanced Breast Cancer

/ Antonio Llombart-Cussac
NBCNBrystcancer Play the Video
Qiao Yang

Quantifying ER Expression: The Key to Personalizing Treatment in HER2-Negative ER-positive Breast Cancer

/ Qiao Yang
NBCNSABCS25Brystcancer Play the Video

Forbedret PFS og OS ved tidlig HER2-positiv og metastatisk triple-negativ brystkræft

/ Hanne Melgaard Nielsen / Jan Andreasen
ESMO25HER2NBCNBrystcancer
Aleksandar Kostov

BRCA Testing in Denmark: Surgical Impact and Survival

/ Aleksandar Kostov
NBCNBrystcancer Play the Video

DESTINY-Breast11 and Neoadjuvant T-DXd: Insights from Finland

/ Maria Sundvall / Jan Andreasen
ESMO25NBCNBrystcancer

Emerging Treatment for High-Risk HER2-Positive Early Breast Cancer — A new therapeutic option for the primary refractory patients 

/ Jan Andreasen
ESMO25Brystcancer

SABCS 2025: Favorable Benefit–Risk Profile of Sacituzumab Govitecan in Previously Untreated Metastatic TNBC PD-L1–ineligible Metastatic Triple-Negative Breast Cancer

/ Jan Andreasen
NBCNSABCS25Brystcancer
Kirsten Marie Woolpert

SABCS 2025: Patterns of Opioid Use Among Breast Cancer Survivors

/ Kirsten Marie Woolpert
NBCNSABCS25Brystcancer Play the Video
Sandra Jensen

Metastatic Deposit Size as a Predictor of Axillary Disease After Neoadjuvant Chemotherapy

/ Sandra Jensen
NBCNBrystcancer Play the Video

HER2-negative Breast Cancer – A Pathologist’s Perspective

/ Gilead
Brystcancer
Peeter Karihtala

The Clinical Value of Immuno-Oncological Treatments in Early Breast Cancer

/ Peeter Karihtala
NBCNOnkologiapäivät 2025Brystcancer Play the Video
Hent flere
Back to top